Abstract
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive procedure whereby a pulsed magnetic field stimulates electrical activity in the brain. Parkinson's disease (PD) is a neurodegenerative process characterized by numerous motor and nonmotor clinical manifestations for which effective, mechanism-based treatments remain elusive. Consequently, more advanced non-invasive therapeutic methods are required. A possible method of rehabilitation that may be effective and potentially viable for use in clinical practice is rTMS. Here, we focus on the basic foundation of rTMS, the main findings of rTMS from animal models, the effects of rTMS on sensorimotor integration in patients with PD, and the experimental advances of rTMS that may become a viable clinical application to treat the disease.
Keywords: rTMS, Parkinsons disease, cellular and molecular mechanisms, Neurorehabilitation, Sensorimotor integration, Deep brain stimulation, HPLC, Prefrontal cortex, L-DOPA, iTBS
CNS & Neurological Disorders - Drug Targets
Title: Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?
Volume: 10 Issue: 6
Author(s): Oscar Arias-Carrion, Sergio Machado, Flavia Paes, Bruna Velasques, Silmar Teixeira, Lizbeth Cardenas-Morales, Roberto Piedade, Pedro Ribeiro and Antonio E. Nardi
Affiliation:
Keywords: rTMS, Parkinsons disease, cellular and molecular mechanisms, Neurorehabilitation, Sensorimotor integration, Deep brain stimulation, HPLC, Prefrontal cortex, L-DOPA, iTBS
Abstract: Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive procedure whereby a pulsed magnetic field stimulates electrical activity in the brain. Parkinson's disease (PD) is a neurodegenerative process characterized by numerous motor and nonmotor clinical manifestations for which effective, mechanism-based treatments remain elusive. Consequently, more advanced non-invasive therapeutic methods are required. A possible method of rehabilitation that may be effective and potentially viable for use in clinical practice is rTMS. Here, we focus on the basic foundation of rTMS, the main findings of rTMS from animal models, the effects of rTMS on sensorimotor integration in patients with PD, and the experimental advances of rTMS that may become a viable clinical application to treat the disease.
Export Options
About this article
Cite this article as:
Arias-Carrion Oscar, Machado Sergio, Paes Flavia, Velasques Bruna, Teixeira Silmar, Cardenas-Morales Lizbeth, Piedade Roberto, Ribeiro Pedro and E. Nardi Antonio, Is rTMS an Effective Therapeutic Strategy that Can Be Used to Treat Parkinson's Disease?, CNS & Neurological Disorders - Drug Targets 2011; 10 (6) . https://dx.doi.org/10.2174/187152711797247821
DOI https://dx.doi.org/10.2174/187152711797247821 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Neurophysiological Mechanisms Related to Pain Management in Bone Tumors
Current Neuropharmacology Glucose Blood Levels as a Therapeutic Target in Acute Ischaemic Stroke Setting
Current Topics in Medicinal Chemistry Kainic Acid-Induced Neurotoxicity: Targeting Glial Responses and Glia-Derived Cytokines
Current Neuropharmacology In Vivo Bioluminescence Imaging to Assess Pancreatic Islets
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Synchrotron Radiation in Life Sciences
Protein & Peptide Letters Prospects for A Schistosome Vaccine
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Psychosocial Stress, Emotions and Cytokine-Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery The Biotin Enzyme Family: Conserved Structural Motifs and Domain Rearrangements
Current Protein & Peptide Science Zinc Supplementation in Preterm Neonates with Jaundice: Is it Beneficial?
Endocrine, Metabolic & Immune Disorders - Drug Targets Adult and Embryonic Stem Cells in Cartilage Repair
Current Rheumatology Reviews Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
CNS & Neurological Disorders - Drug Targets Developments in Imaging Technologies Related to Hypertensive Cardiovascular Diseases
Current Pharmaceutical Design Sleep and Antidepressant Treatment
Current Pharmaceutical Design Neuronal Ceroid Lipofuscinosis: The Increasing Spectrum of an Old Disease
Current Molecular Medicine Mosquito and Tick-borne Illnesses in the United States. Guidelines for the Recognition and Empiric Treatment of Zoonotic Diseases in the Wilderness.
Infectious Disorders - Drug Targets The Use of the Zebrafish Model to Aid in Drug Discovery and Target Validation
Current Topics in Medicinal Chemistry Polymer-Based Drug Delivery Devices for Neurological Disorders
CNS & Neurological Disorders - Drug Targets HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued)